(Q54296229)

27 May 2018

title

The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors. (English)

1 reference

27 May 2018

1 reference

acute myeloid leukemia

1 reference

3

1 reference

27 May 2018

author name string

C Fialin

1

1 reference

27 May 2018

C Larrue

2

1 reference

27 May 2018

J E Sarry

4

1 reference

27 May 2018

S Bertoli

5

1 reference

27 May 2018

V Mansat-De Mas

6

1 reference

27 May 2018

C Demur

7

1 reference

27 May 2018

E Delabesse

8

1 reference

27 May 2018

B Payrastre

9

1 reference

27 May 2018

S Manenti

10

1 reference

27 May 2018

S Roche

11

1 reference

27 May 2018

C Récher

12

1 reference

27 May 2018

publication date

20 August 2012

1 reference

27 May 2018

published in

Leukemia

1 reference

27 May 2018

volume

27

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

325-335

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2012.240

exact match

0 references

cites work

Genetics of myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

FLT3 inhibition as a targeted therapy for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

A critical role for Lyn in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Ron-receptor tyrosine kinase in tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Fv2 encodes a truncated form of the Stk receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Antileukemic activity of rapamycin in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Exploiting signal transduction pathways in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

inferred from DOI database lookup

7 January 2021

based on heuristic

Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.240

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2012.240

1 reference

27 May 2018

PubMed ID

22902361

1 reference

27 May 2018